Use of lung cancer screening tests in the United States: Results from the 2010 National Health Interview Survey

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 7, 2012, Pages 1049-1059

  Doria Rose, V Paul ^a   White, Mary C ^b   Klabunde, Carrie N ^a   Nadel, Marion R ^b   Richards, Thomas B ^b   McNeel, Timothy S ^c   Rodriguez, Juan L ^b   Marcus, Pamela M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LOW DOSE COMPUTER ASSISTED TOMOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL HEALTH INTERVIEW SURVEY; POPULATION SIZE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RACE DIFFERENCE; RADIATION DOSE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SENESCENCE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING HABIT; THORAX RADIOGRAPHY; UNITED STATES;

ADENOCARCINOMA; ADULT; EARLY DETECTION OF CANCER; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; LUNG NEOPLASMS; MALE; QUESTIONNAIRES; RADIOGRAPHY, THORACIC; RISK FACTORS; SMOKING; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863596647     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0343     Document Type: Article

References (38)

1. U.S. Cancer Statistics Working Group. United States cancer statistics: 1999-2007 incidence and mortality web-based report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010 [cited 2012 Mar 18] Available from: http://apps.nccd.cdc.gov/uscs/.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011 [cited 2012 Mar 1] Available from: http://seer.cancer.gov/csr/ 1975-2008/, based on November 2010 SEER data submission, posted to the SEER web site.
3. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009;115:5007-17.
4. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer 1991;67:1155-64.
5. Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990;45:26-33. (Pubitemid 20032093)
6. Doria-Rose VP, Szabo E. Screening and prevention of lung cancer. In: Kernstine KH, Reckamp KL, editors. Lung cancer: a multidisciplinary approach to diagnosis and management. New York: Demos Medical; 2011. p. 53-72.
7. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. J Am Med Assoc 2011;306:1865-73.
8. Klabunde CN, Marcus PM, Han PK, Richards TB, Vernon SW, Yuan G, et al. Lung cancer screening practices of primary care physicians: results from a national survey. Ann Family Med 2012;10:102-10.
9. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105. (Pubitemid 29313143)
10. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
11. U.S. Preventive Services Task Force. Lung cancer screening: recommendation statement. Ann Intern Med 2004;140:738-9.
12. Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:69S-77S. (Pubitemid 47502800)
13. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:740-53.
14. NCCN clinical practice guidelines in oncology: lung cancer screening. Fort Washington, PA: National Comprehensive Cancer Network; 2011. [cited 2012 Mar 18] Available from: http://www.nccn.org/professionals/physician-gls/f- guidelines.asp.
15. 2010 NHIS Questionnaire- Sample Adult. [cited 2012 Mar 18] Available from: ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS/Survey-Questionnaires/NHIS/ 2010/English/qcancer.pdf.
16. Adams PF, Martinez ME, Vickerie JL, Kirzinger WK. Summary health statistics for the U. S. population: National Health Interview Survey 2010. Vital Health Stat 2011;10(251). [cited 2012 Mar 18] Available from: http://www.cdc.gov/nchs/data/series/sr-10/sr10-251.pdf.
17. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey 2010. Vital Health Stat 2012;10(252); [cited 2012 Mar 18] Available from: http://www.cdc.gov/nchs/data/ series/sr-10/sr10-252.pdf.
18. Klabunde CN, Marcus PM, Silvestri GA, Han PK, Richards TB, Yuan G, et al. U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prevent Med 2010;39:411-20.
19. Habbema D, De Kok IM, Brown ML. Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q 2012;90:5-37.
20. Peres J. Lung cancer screening: ready for prime time? J Natl Cancer Inst 2011;103:89-91.
21. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med 2002;346:529-31. (Pubitemid 34441749)
22. U.S. Preventive Services Task Force. Rockville, MD. [cited 2012 Mar 18] Available from: http://www.uspreventiveservicestaskforce.org/uspstf/topicsprog. htm.
23. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004;231:440-5. (Pubitemid 38552902)
24. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84. (Pubitemid 350190758)
25. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009;169:2078-86.
26. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001;345:181-8. (Pubitemid 32662128)
27. Finlayson EV, Birkmeyer JD. Operative mortality with elective surgery in older adults. Eff Clin Pract 2001;4:172-7.
28. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006;98:748-56. (Pubitemid 43983298)
29. Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax 2008;63:377-83. (Pubitemid 351497954)
30. Brown KT, Brody LA, Getrajdman GI, Napp TE. Outpatient treatment of iatrogenic pneumothorax after needle biopsy. Radiology 1997;205:249-52. (Pubitemid 27415156)
31. Cox JE, Chiles C, McManus CM, Aquino SL, Choplin RH. Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology 1999;212:165-8. (Pubitemid 29302530)
32. Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology 2003;229:475-81. (Pubitemid 37310835)
33. Gupta S, Krishnamurthy S, Broemeling LD, Morello FA Jr, Wallace MJ, Ahrar K, et al. Small (
34. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-8.
35. Feig S. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am 2010;48:879-91.
36. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 2011;33:88-100.
37. Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, et al. Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev 2009;18:1699-705.
38. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Reding DJ, Hayes RB, et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology 2009;138:73-81.